| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . |
# |
Score |
Template |
Links and tools | %id | First |
MLEQMGIAAKQASYKLAQLSSREKNRVLEKIADELEAQSEIILNANAQDVADARANGLSEAMLDRLALTPARLKGIADDVRQVCNLADPVGQVIDGGVLDSGLRLERRRVPLGVIGVIYEARPNVTVDVASLCLKTGNAVILRGGKETCRTNAATVVVIQDALKSCGLPAGAVQAIDNPDRALVSEMLRMDKYIDMLIPRGGAGLHKLCREQSTIPVITGGIGVCHIYVDESAEIAEALKVIVNAKTQRPSTCNTVETLLVNKNIAYSFLPALSKQMAESGVTLHADASALAQLQTGPAKVVAVKAEEYDDEFLSLDLNVKIVSDLDDAIAHIREHGTQHSDAILTRDMRNAQRFVNEVDSSAVYVNASTRFTDGGQFGLGAEVAVSTQKLHARGPMGLEALTTYKWIGIGDYTIRA | Last |
1 | -4.570 | tr|E9PHR9|E9PHR9_HUMAN Uncharacterized protein OS=Homo sapiens GN=PLSCR4 PE=4 SV=1 |
ali |
14 | 2 | ..............................................................................................................PMGYYSPQQPSTFPLYQPVGG-----IHPVRYQPGKYPMPNQSVPITWMPGPTPMANCPPGL..................................................................................................................................................................................................................................................... |
58 |
2 | -4.420 | sp|Q6PJ69|TRI65_HUMAN Tripartite motif-containing protein 65 OS=Homo sapiens GN=TRIM65 PE=1 SV=3 |
ali |
14 | 1 | ..EGQLLELRKQSSQIQNSACILASGKFSSLLQALEIQHTTALRS--IEVAKTQALAQARDEEQRLRVHLEAVARHGCRIRELLEQVDEQ....................................................................................................................................................................................................................................................................................................................................... |
89 |
3 | -4.180 | sp|A0AVK6|E2F8_HUMAN Transcription factor E2F8 OS=Homo sapiens GN=E2F8 PE=1 SV=1 |
ali |
16 | 1 | .......................................................................................KPVAPLDPPVNAEMELTAPSLIQPLGMVPLI-PSPLSSAVPLILPQAPSG-AIYLQPTQAHQSVT......................................................................................................................................................................................................................................................................... |
66 |
4 | -3.950 | sp|Q5T7B8|KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens GN=KIF24 PE=1 SV=2 |
ali |
17 | 10 | .LDEMAELGFKEETLMSQLASNDFEDFVTQLDEIMVLKSKCIQSLRSQ................................................................................................................................................................................................................................................................................................................................................................................. |
56 |
5 | -3.920 | sp|Q9BXF3|CECR2_HUMAN Cat eye syndrome critical region protein 2 OS=Homo sapiens GN=CECR2 PE=1 SV=2 |
ali |
15 | 39 | ..............SFQDLPLRTRVEILHRLCDYRLDADDVFDLLKGLDADSLRVEPLG...................................................................................................................................................................................................................................................................................................................................................................... |
83 |
6 | -3.890 | sp|Q9Y4X5|ARI1_HUMAN E3 ubiquitin-protein ligase ARIH1 OS=Homo sapiens GN=ARIH1 PE=1 SV=2 |
ali |
14 | 53 | FLKKAVDVLCQCRATLM-LKKNNQSIIFENNQADLENATEVLSGYLERDISQDSLQDIKQKVQDKYRYCESRRRVLLQHVHE............................................................................................................................................................................................................................................................................................................................................... |
141 |
7 | -3.880 | sp|Q9BXQ6|CECR6_HUMAN Cat eye syndrome critical region protein 6 OS=Homo sapiens GN=CECR6 PE=2 SV=1 |
ali |
19 | 2 | ........................................................................................................LIELRAPFGTTGF----------------------------RLTMALSVPLLYSLVRAISEAGAPPGSAGPLLLQPQRHRAAGCFLGTCLDLL---DSFTLVELMLEG............................................................................................................................................................................................................. |
78 |
8 | -3.860 | sp|Q13200|PSMD2_HUMAN 26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiens GN=PSMD2 PE=1 SV=3 |
ali |
8 | 1 | ........................QDELEMLVERLGEKDTSLYRP--------------EELRRQIRSSTTSMTSVPKPLKFLRPHYGKLKEIYENMAPGENKRF------AADIISVLAMTMSGERECLKYRLVGSQEELASWGHE--YVRHLAGEVAKEWQELDDAEKVQREPLLTLVKEIVPYNMAHNEACDLLMEIEQVDMLEKDIDENAYAKVCLYLTSCVNYVPEPEN-SALLRCALGVFRKFSRFPEALRLAL-DMELVEDIFTSCKDVVVQKQMAF-GRHGVFLELSEDVEEYEDLTEIMSNVQLNSNFLALARELDIMEPKVPDDIYKTHLENNRFGGSGSQVDS--ARMNLASSFVNGFV------------NAAFGQDKL.......................... |
338 |
9 | -3.850 | sp|Q9ULT8|HECD1_HUMAN E3 ubiquitin-protein ligase HECTD1 OS=Homo sapiens GN=HECTD1 PE=1 SV=3 |
ali |
15 | 1 | ...........................................................................................................VSTIVSLLSTLCRGSPVVTHDLLRSELPDSIESALQGDERCVLDTMRLVDLLLVLLFE............................................................................................................................................................................................................................................................ |
58 |
10 | -3.830 | sp|Q8N2C7|UNC80_HUMAN Protein unc-80 homolog OS=Homo sapiens GN=UNC80 PE=2 SV=2 |
ali |
11 | 11 | ICTEFYKHCGPRLKILQNLAGEPRVIALELL--RLAEIAHSLLKLAPYDTQTMESRGLRRYIMEMLPITDWTAEAVRPALILILKRLDRMFNKIHKMPTLRRQVEWEPASNLGVCLTLQRQPIISFLPHLRSLINVCVNLVMVVGPSSVADGLPLLHLSPYLSPPLPFSTAVVRLVA-----QIQALKEDFPLSHVISPFTNQERREGMLLNLLIPFLTVGSGSKDSPWLEQPEVQLLLQTVINV............................................................................................................................................................................ |
259 |